Pesquisar
Nyxoah SA
NYXHAdicionar à lista de desejos
1.720USD
-0.060-3.37%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
74.01MValor de mercado
PerdaP/L TTM
Mais detalhes de Nyxoah SA Empresa
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Informações de Nyxoah SA
Código da empresaNYXH
Nome da EmpresaNyxoah SA
Data de listagemSep 18, 2020
CEOTaelman (Olivier)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 18
EndereçoRue Edouard Belin 12
CidadeMONT-SAINT-GUIBERT
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísBelgium
Código postal1435
Telefone3226121755
Sitehttps://www.nyxoah.com/
Código da empresaNYXH
Data de listagemSep 18, 2020
CEOTaelman (Olivier)
Executivos da empresa Nyxoah SA
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Francis Kim
Mr. Francis Kim
Chief Regulatory and Quality Officer
Chief Regulatory and Quality Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Nyxoah SA?
Os cinco principais acionistas de Nyxoah SA são: Mr. Robert Taub
Quantas instituições possuem ações da Nyxoah SA (NYXH)?
Em 2026Q1, 79 instituições possuíam ações da Nyxoah SA, com valor de mercado aproximado de 9.38M, representando 21.47% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -824223.00.